60

Xinjiang Bai Hua Cun Pharma Tech Co LtdSHG 600721 Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.354

Micro

Exchange

XSHG - Shanghai Stock Exchange

600721.SS Stock Analysis

60

Uncovered

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

24/100

Low score

Market cap $B

0.354

Dividend yield

Shares outstanding

377.67 B

Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.

View Section: Eyestock Rating